Study limitation: No specific dose thresholds for de-escalation were defined; findings support feasibility but not a formal dose recommendation | ReachRx
Prognostic impact of radiotherapy dose to the axilla in cN + /ypN0 breast cancer after primary systemic therapy and sentinel lymph node biopsy: toward true de-escalation of axillary management
Study limitation reported by the research below: “No specific dose thresholds for de-escalation were defined; findings support feasibility but not a formal dose recommendation.”